An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for ...

A third "just in case" service to proactively store induced pluripotent stem (iPS) cells created with a client's blood for potential use if they develop future medical issues is s ...

Cellares is advancing the global expansion of its state-of-the-art automated cell therapy manufacturing platform. The company announced May 29, in collaboration with Mitsui Fudosan, the establishment ...

Hyundai Motor Group (HMG) launched its dedicated ‘HTWO’ hydrogen brand and business platform in Japan this week, at the H2&FC ...

Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients ...

Japan continues to position itself as a global leader in regenerative medicine through its progressive regulatory framework tailored to the unique characteristics of cell, tissue, and gene therapy ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers from Nagoya University, led by Atsushi Noro, have introduced a groundbreaking phosphonic acid polymer electrolyte that ...

Japan has approved two pioneering stem-cell therapies for the treatment of Parkinson’s disease and severe heart failure, marking a major milestone in ...